Save information for later
Sign Up

Learn About Tetralogy of Fallot

What is the definition of Tetralogy of Fallot?
Tetralogy of Fallot is a complex congenital heart defect characterized by a large ventricular septal defect (hole between the right and left ventricles), pulmonary stenosis (narrowing of the valve and artery that connect the heart with the lungs), an overriding aorta (the aorta - the artery that carries oxygen-rich blood to the body - is shifted over the right ventricle and ventricular septal defect, instead of coming out only from the left ventricle), and right ventricular hypertrophy (the muscle of the right ventricle is thicker than usual). Tetralogy of Fallot causes low oxygen levels in the blood, which can lead to cyanosis (a bluish-purple color to the skin). The cause of this condition is unknown.
What are the alternative names for Tetralogy of Fallot?
  • Tetralogy of Fallot
  • Fallot tetralogy
  • TOF
Who are the top Tetralogy of Fallot Local Doctors?
Bryan H. Goldstein
Elite in Tetralogy of Fallot
Elite in Tetralogy of Fallot

Pediatric Cardiology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Bryan H. Goldstein MD, FACC, FSCAI is a pediatric interventional cardiologist and is certified in pediatric cardiology by the American Board of Pediatrics. He is director of the cardiac catheterization laboratory and interventional cardiology service at UPMC Children’s Hospital of Pittsburgh and is a Professor of Pediatrics at the University of Pittsburgh School of Medicine. He received his medical degree from Boston University School of Medicine and completed his residency at the Boston Combined Residency in Pediatrics (Children’s Hospital Boston) and fellowship at C.S. Mott Children’s Hospital (University of Michigan Medicine). Dr. Goldstein joined the UPMC Heart and Vascular Institute in 2019. His clinical interests include congenital cardiac catheterization, minimally invasive transcatheter therapies, and single ventricle (Fontan) circulation. Dr. Goldstein has published numerous scientific articles in peer-reviewed journals, is a frequent faculty member and presenter at national and international meetings, and is a member of Alpha Omega Alpha Honor Medical Society, American Academy of Pediatrics (FAAP), American Heart Association, American College of Cardiology (FACC) and Society for Cardiovascular Angiography & Interventions (FSCAI). He is vice president of the Congenital Cardiac Research Collaborative (CCRC). View Dr. Goldstein's full list of publications from PubMed. Dr. Goldstein is rated as an Elite provider by MediFind in the treatment of Tetralogy of Fallot. His top areas of expertise are Congenital Cardiovascular Shunt, Tetralogy of Fallot, Pulmonary Atresia, Stent Placement, and Angioplasty.

Paul Khairy
Elite in Tetralogy of Fallot
Elite in Tetralogy of Fallot
5000 Bélanger St, 
Montreal, QC, CA 

Paul Khairy practices in Montreal, Canada. Mr. Khairy is rated as an Elite expert by MediFind in the treatment of Tetralogy of Fallot. His top areas of expertise are Congenital Heart Disease (CHD), Tetralogy of Fallot, Atrial Fibrillation, Cardiac Ablation, and Heart Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Michael A. Gatzoulis
Elite in Tetralogy of Fallot
Elite in Tetralogy of Fallot
Dovehouse St, 
London, ENG, GB 

Michael Gatzoulis practices in London, United Kingdom. Mr. Gatzoulis is rated as an Elite expert by MediFind in the treatment of Tetralogy of Fallot. His top areas of expertise are Tetralogy of Fallot, Congenital Heart Disease (CHD), Eisenmenger Syndrome, Heart Transplant, and Patent Foramen Ovale Repair.

What are the latest Tetralogy of Fallot Clinical Trials?
A Multi-center, Randomized, Controlled Investigation of Tetralogy of Fallot in Neonates

Summary: Child health serves as the foundation for overall public health, with neonatal mortality recognized globally as a comprehensive indicator of national health standards and societal advancement. The Healthy Children Action Improvement Plan (2021-2025) sets a national target to reduce neonatal mortality in China to below 3.1‰. Congenital heart disease (CHD), the most prevalent congenital defect among...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In Tetralogy of Fallot

Summary: Heart failure is a common long-term complication in patients with congenital heart disease (CHD). Medical treatments to promote regeneration of new healthy heart muscle cells have the potential to provide new heart failure treatments for these patients. The development of such therapies is limited by the poor understanding of the ways in which heart muscles grow after birth. Investigators have lea...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center